Sweden· SE-20120706000099
Imnovid 2 mg Kapsel, hård
A medicinal product containing pomalidomide, registered in Sweden by Bristol-Myers Squibb Pharma EEIG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Pomalidomide
- Manufacturer
- Bristol-Myers Squibb Pharma EEIG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20120706000099
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pomalidomide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIMNOVIDBristol-Myers Squibb Pharma EEIG, Dublin
- NetherlandsImnovid 2 mg, harde capsulesBristol-Myers Squibb Pharma EEIG
- SwitzerlandImnovid
- United StatespomalidomideNovadoz Pharmaceuticals LLC
- PolandImnovidBristol-Myers Squibb Pharma EEIG
- FinlandImnovidBristol-Myers Squibb Pharma EEIG
- SpainIMNOVID 2 MG CAPSULAS DURASBristol-Myers Squibb Pharma Eeig
- United KingdomImnovid 2mg capsulesOriginalis B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Pomalidomid +pharma, Pomalidomid Devatis
- Belgium · Pomalidomide Eg, Pomalidomide Eugia
- Bulgaria · Помалидомид Devatis, Помалидомид Булгермед
- Cyprus · Pomalidomide, Pomalidomide Adalvo
- Czechia · Pomalidomid Sanexcel, Pomalidomide Abdi
- Germany · Pomadel, Pomalidomid 123 Acurae Pharma
- Denmark · Pomalidomid Devatis, Pomalidomid Grindeks
- Estonia · Pomalidomide Grindeks, Pomalidomide Olpha
- Spain · Pomalidomida Abdi, Pomalidomida Erawya
- Finland · Pomalidomid Avansor, Pomalidomid Devatis
- France · Pomalidomide Eg, Pomalidomide Eugia
- United Kingdom (Northern Ireland) · Pomalidomide, Pomalidomide Amarox
- Greece · Polidma, Pomalidomide Anabiosis
- Hungary · Pomalidomid Onkogen, Pomalidomide Grindeks
- Ireland · Pomalidomide Clonmel, Pomalidomide Grindeks
- Iceland · Imnovid, Pomalidomide Accord
- Italy · Pomalidomide Abdi, Pomalidomide Aurobindo
- Liechtenstein · Imnovid, Pomalidomide Accord
- Lithuania · Pomalidomide Grindeks, Pomalidomide Olpha
- Luxembourg · Pomalidomide Eg, Pomalidomide Eugia
- Latvia · Pomalidomide Grindeks, Pomalidomide Olpha
- Malta · Pomalidomide, Pomalidomide Clonmel
- Netherlands · Polidma, Pomalidomide Adalvo
- Norway · Imnovid, Pomalidomid Devatis
- Poland · Pomalidomid Reig Jofre, Pomalidomide Eugia
- Portugal · Pomalidomida Aurobindo, Pomalidomida Bluepharma
- Romania · Pomalidomidă Dr. Reddy’s, Pomalidomidă Grindeks
- Slovenia · Pomadel, Pomalidomid Grindeks
- Slovakia · Pomalidomid Grindeks, Pomalidomid Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fab12ac7-58d7-4a3d-af01-bd159bd93332 GET /v1/drugs/fab12ac7-58d7-4a3d-af01-bd159bd93332?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20120706000099",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20120706000099",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/imnovid-epar-product-information_sv.pdf"
}See everything about pomalidomide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.